He has also held executive roles at Alchemab Therapeutics and TScan Therapeutics and spent over a decade at Eli Lilly and Company in corporate business development and global partnerships. Dr.

The first half of 2025 has been marked by a surge in strategic activity across the global healthcare, life sciences, and ...

Telehealth partners for Eli Lilly (LLY) continue to sell compounded GLP-1 weight-loss drugs despite an agreement with the pharma giant to end copycat sales after the FDA ended a years-long ...

In recent times, though, Lilly has become less expensive, as the stock slipped 12% from a high reached in March. Is Lilly a buy on the dip? Let's find out. Image source: Getty Images.

Eli Lilly and Company (LLY)’s share was trading at $765.68 as of 5th June. LLY’s trailing and forward P/E were 62.30 and 35.09 respectively according to Yahoo Finance.

INDIANAPOLIS, June 23, 2025 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2025 of $1.50 per ...

An experimental weight-loss drug from Eli Lilly & Co. helped patients lose weight with few side effects, according to the summary of a small study that suggests the company has another foothold in ...

It's the remarkable true story of one woman's fight for equal pay that impacts us all! Oscar-nominated actress Patricia Clarkson joined us to talk about her starring role in the new movie "Lilly ...

Nova Scotia's Royal Canadian Mounted Police (RCMP) announced on Wednesday that investigators have conducted polygraph interviews as part of the effort to determine what happened to Lilly and Jack ...